This course will take learners on an informative journey through the glucose cosmos. Course content will discuss the evolution of continuous glucose monitors (CGMs) while highlighting their profound impact on enhancing health outcomes and quality of life for individuals with diabetes. Learners will explore CGM utilization across diverse diabetic patient populations, and discover the pivotal role that pharmacy teams play in integrating CGM devices into comprehensive diabetes management strategies. By course end, learners will emerge as empowered guardians equipped to leverage CGM technology in their mission to optimize patient care and conquer the challenges of glucose control.

Upon successful completion of this knowledge-based CPE course, pharmacists should be able to:
1. Describe the evolution of Continuous Glucose Monitors (CGMs).
2. Recognize the impact of CGM devices in improving the health, clinical outcomes, and quality of life for persons living with diabetes.
3. Discuss the use of CGM devices in the management of diabetes across patient populations.
4. Explain the role of the pharmacist in managing people with diabetes and the opportunity to integrate CGM devices into practice.

Susan Cornell, PharmD, CDCES, FAPhA, FADCES
Professor, Pharmacy Practice, Diabetes Care & Education Specialist
Midwestern University College of Pharmacy

Dr. Cornell is on the advisory board of Novo Nordisk Inc. All financial relationships have been mitigated.

Financial support was provided for this course through an unrestricted educational grant from Abbott Diabetes Care.

Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Initial Release Date: June 13, 2024
Planned Expiration Date: June 13, 2027

Copyright 2024, CEimpact. All Rights Reserved. Any reproduction of this course without express permission is strictly forbidden.